Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model
2021 ◽
Vol Volume 16
◽
pp. 3105-3118
1988 ◽
Vol 126
◽
pp. 641-642
Keyword(s):
1998 ◽
Vol 184
◽
pp. 487-488
Keyword(s):
1990 ◽
Vol 141
◽
pp. 427-429
Keyword(s):
Keyword(s):